A. Rolaki

Novel trends in follicular development, atresia and corpus luteum regression: a role for apoptosis.

Dimitris Loutradis, A. Rolaki, P. Drakakis, 2005, Reproductive biomedicine online.

Adverse Outcome Pathway on inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment

A. Rolaki, F. Pistollato, S. Munn, 2019, OECD Series on Adverse Outcome Pathways.

Putative adverse outcome pathways relevant to neurotoxicity

K. Crofton, A. Rolaki, C. Suñol, 2015, Critical reviews in toxicology.

Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children

A. Rolaki, A. Bal-Price, M. Sachana, 2018, Toxicology and applied pharmacology.

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation

N. Pavlidis, U. Jeschke, A. Rolaki, 2007, British Journal of Cancer.

Luteogenic Hormones Act through a Vascular Endothelial Growth Factor-Dependent Mechanism to Up-Regulate α5β1 and αvβ3 Integrins, Promoting the Migration and Survival of Human Luteinized Granulosa Cells

G. Coukos, H. DeLisser, A. Rolaki, 2007 .

Partition coefficient and diffusion coefficient determinations of 50 compounds in human intact skin, isolated skin layers and isolated stratum corneum lipids.

A. Rolaki, N. Hewitt, J. Manwaring, 2020, Toxicology in vitro : an international journal published in association with BIBRA.

Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: II. A focus on growth impairment in fish.

Cheryl A Murphy, Cheryl A. Murphy, Kristin Schirmer, 2015, Chemosphere.

Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: I. Challenges and research needs in ecotoxicology.

Cheryl A Murphy, Cheryl A. Murphy, Kristin Schirmer, 2015, Chemosphere.